Virulence-attenuating genetic deletions deleted from mycobacterium BCG
AssigneePathoGenesis Corporation
InventorsCharles Kendall Stover, Gregory G. Mahairas
Life of this patent
Estimating the term…
Abstract
The present invention provides specific genetic deletions that result in an avirulent phenotype of a mycobacterium. These deletions may be used as phenotypic markers of providing a means for distinguishing between disease-producing and non-disease producing mycobacteria.
Claims57
An isolated marker for an avirulent mycobacterium, said marker comprising a first nucleic acid that specifically hybridizes under stringent conditions with a second nucleic acid or a complement of said second nucleic acid where said second nucleic acid or complement of said second nucleic acid is selected from the group consisting of BCG.DELTA.1a (SEQ ID NO:
- 1), BCG.DELTA.1b (SEQ ID NO:
- 2), BCG.DELTA.2a (SEQ ID NO:
- 3), BCG.DELTA.2b (SEQ ID NO:
- 4), BCG.DELTA.3a (SEQ ID NO:
- 5), BCG.DELTA.3b (SEQ ID NO:
- 6), BCG.DELTA.1ab (SEQ ID NO:
- 7), BCG.DELTA.2ab (SEQ ID NO:
- 8), BCG.DELTA.3ab (SEQ ID NO:
- 9), BCG.DELTA.1 (between nucleotide 2327 and nucleotide 11126 of SEQ ID NO:
- 16), BCG.DELTA.3 (between nucleotide 1406 and nucleotide 10673 of SEQ ID NO:
- 18), ORF 2B2 (nucleotides 3003-3590 of SEQ ID NO:
- 17), ORF 2C (nucleotides 5187-6134 of SEQ ID NO:
- 17), ORF 2D (nucleotides 6561-7217 of SEQ ID NO:
- 17), ORF 2E (nucleotides 8036-8560 of SEQ ID NO:
- 17), ORF 2F (nucleotide 9941-10909 of SEQ ID NO:
- 17), ORF 2H (nucleotides 11965-13407 of SEQ ID NO:
- 17), ORF 2I (nucleotides 13376-14221 of SEQ ID NO:
- 17), ORF 2J (nucleotides 7211-8259 of SEQ ID NO:
- 17), ORF 2K (nucleotides 4327-4992 of SEQ ID NO:
- 17), and ORF 2L (nucleotides 4521-5117 of SEQ ID NO:
- 17);
- wherein said marker specifically hybridizes under stringent conditions to a nucleic acid from BCG, but not to a nucleic acid from Mycobacterium tuberculosis or Mycobacterium bovis, or where said marker specifically hybridizes under stringent conditions to a nucleic acid from Mycobacterium tuberculosis or Mycobacterium bovis, but not to a nucleic acid from BCG.
A recombinant cell transfected with a first nucleic acid wherein said first nucleic acid hybridizes under stringent conditions with a second nucleic acid or a complement of said second nucleic acid where said second nucleic acid or complement of said second nucleic acid is selected from the group consisting of BCG.DELTA.1a (SEQ ID NO:
- 1), BCG.DELTA.1b (SEQ ID NO:
- 2), BCG.DELTA.2a (SEQ ID NO:
- 3), BCG.DELTA.2b (SEQ ID NO:
- 4), BCG.DELTA.3a (SEQ ID NO:
- 5), BCG.DELTA.3b (SEQ ID NO:
- 6), BCG.DELTA.1ab (SEQ ID NO:
- 7), BCG.DELTA.2ab (SEQ ID NO:
- 8), BCG.DELTA.3ab (SEQ ID NO:
- 9), BCG.DELTA.1 (between nucleotide 2327 and nucleotide 11126 of SEQ ID NO:
- 16), BCG.DELTA.3 (between nucleotide 1406 and nucleotide 10673 of SEQ ID NO:
- 18), ORF 2B2 (nucleotides 3003-3590 of SEQ ID NO:
- 17), ORF 2C (nucleotides 5187-6134 of SEQ ID NO:
- 17), ORF 2D (nucleotides 6561-7217 of SEQ ID NO:
- 17), ORF 2E (nucleotides 8036-8560 of SEQ ID NO:
- 17), ORF 2F (nucleotide 9941-10909 of SEQ ID NO:
- 17), ORF 2H (nucleotides 11965-13407 of SEQ ID NO:
- 17), ORF 2I (nucleotides 13376-1422 of SEQ ID NO:
- 17), ORF 2J (nucleotides 7211-8253 of SEQ ID NO:
- 17), ORF 2K (nucleotides 4327-4992 of SEQ ID NO:
- 17), and ORF 2L (nucleotides 4521.5117 of SEQ ID NO:
- 17).
Dependencies are inferred from the claim text.